Pulmonary aspergillosis in solid organ transplant patients: a report from Iran

M. Marjani, P. Tabarsi, K. Najafizadeh, M. R. Masjedi, D. Mansouri (Tehran, Islamic Republic Of Iran)

Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous
Session: Lung and bone marrow transplantation: miscellaneous
Session type: E-Communication Session
Number: 1635
Disease area: Respiratory infections

Congress or journal article abstract

Abstract

Background. Aspergillosis is one of the most important opportunistic infections after organ transplantation. Early diagnosis and initiation of appropriate antifungal therapy are key factors for better prognosis.
Aims. In this study, we report our experience with invasive pulmonary Aspergillus infections in Lung, heart and kidney transplant recipients, in our institution and examine the risk factors associated with this complication and outcome of treatment.
Methods. We reviewed the medical records of patients with solid organ transplantation with evidence of Aspergillus infections in National Research Institute of Tuberculosis and Lung Disease in Iran from December 2001 to January 2008 and evaluated patient‘s demographics, the time of onset after transplantation, risk factors, radiologic appearance, diagnostic criteria, antifungal therapy and outcome.
Results. We found Aspergillosis in eight lung, three kidney and one heart recipients, with a mean age of 40.6 years. Seven cases of Aspergillus tracheobronchitis were diagnosed in lung transplant recipients, all of theme in the first six months after transplantation. All patients responded to antifungal therapy and Bronchoscopic debridement.
We found five cases of invasive pulmonary Aspergillosis. Three of these patients survived with response to antifungal treatment. Two patients who died had been treated with combination of Itraconazole and Amphotericin B. All cured patients had been treated with Voriconazole alone or in combination with Caspofungin.
Conclusions. It seems that the prognosis of Aspergillosis in solid organ recipients is improving with new treatment regimens particularly if they are used in early stages of infection.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Marjani, P. Tabarsi, K. Najafizadeh, M. R. Masjedi, D. Mansouri (Tehran, Islamic Republic Of Iran). Pulmonary aspergillosis in solid organ transplant patients: a report from Iran. Eur Respir J 2008; 32: Suppl. 52, 1635

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Invasive pulmonary aspergillosis in solid organ transplant patients: A CT challenge
Source: Annual Congress 2013 –Morphologic imaging
Year: 2013

Fatal invasive aspergillosis in a non-neutropenic cystic fibrosis patient post liver transplantation
Source: Eur Respir J 2005; 26: Suppl. 49, 402s
Year: 2005

Pulmonary nocardiosis in renal transplant patients in a tertiary care hospital in Pakistan
Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections
Year: 2020


Pulmonary complications in solid organ transplant recipients
Source: Annual Congress 2010 - Managing pulmonary complications in the immunocompomised host
Year: 2010


Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation
Source: Eur Respir J 2012; 39: 1520-1533
Year: 2012



Lung transplantation for lymphangioleiomyomatosis: a Brazilian centre experience.
Source: International Congress 2017 – Rare diseases
Year: 2017


Chronic pulmonary aspergillosis: Characteristics of 30 nonimmunocompromised patients
Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies
Year: 2011

Pulmonary cladophialophora boppii infection in a lung transplant recipient
Source: Eur Respir J 2006; 28: Suppl. 50, 777s
Year: 2006

Pulmonary complications in renal transplant recipients
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009

Invasive pulmonary aspergillosis in immunosuppressed patients
Source: International Congress 2015 – How to approach and treat fungal and viral respiratory infections
Year: 2015



Tuberculosis patterns in patients with renal transplant
Source: Eur Respir J 2007; 30: Suppl. 51, 659s
Year: 2007

Pulmonary veno-occlusive disease is highly prevalent in scleroderma patients undergoing lung transplantation
Source: ERJ Open Res, 5 (1) 00168-2018; 10.1183/23120541.00168-2018
Year: 2019



Pulmonary rehabilitation in patients referred for lung transplantation
Source: Annual Congress 2012 - The latest insights in pulmonary rehabilitation
Year: 2012

Pulmonary infections in renal transplant recipients from tertiary care hospital, SIUT Pakistan
Source: Virtual Congress 2021 – Fungi, viruses, parasites and the immunocompromised
Year: 2021

Pulmonary complications in heart transplant recipients
Source: Eur Respir J 2004; 24: Suppl. 48, 181s
Year: 2004

Pulmonary nocardiosis in immunocompetent patients: can COPD be the only risk factor?
Source: Eur Respir Rev 2011; 20: 210-212
Year: 2011


Pulmonary aspergillosis: a clinical review
Source: Eur Respir Rev 2011; 20: 156-174
Year: 2011



Lung transplantation in systemic sclerosis: Experience in a spanish center
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014


Pulmonary fungal infection in paediatric cancer patients
Source: Eur Respir J 2001; 18: Suppl. 33, 510s
Year: 2001